Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Centocor expands research and development to focus on immune-mediated inflammatory disorders

Oct. 22, 2002

Second phase of RADIUS trial initiated

Oct. 21, 2002

Deltagen discovers novel antibody target for potential treatment of rheumatoid arthritis

Oct. 21, 2002

Japan Energy describes TNF-alpha and IL-6 production inhibitors

Oct. 18, 2002

Beneficial effects of antimalarial agents in ITP and SLE

Oct. 17, 2002

Potential use of a modified anti-CD3 therapy in psoriatic arthritis

Oct. 17, 2002

Rheumatoid arthritis patients in need may receive adalimumab under the ACT program

Oct. 16, 2002

Lexicon Genetics drug target may have potential in arthritis and autoimmune disease

Oct. 16, 2002

ChondroGene and Pfizer enter osteoarthritis collaboration

Oct. 16, 2002

New MMP-2 and/or MMP-13 inhibitors identified at Pharmacia

Oct. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...